Yun-Ping Lee

Title: Innovations by Inventor Yun-Ping Lee

Introduction

Yun-Ping Lee is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of hepatitis B virus (HBV) and chronic liver disease. With a total of 2 patents, his work has the potential to impact the diagnosis and treatment of liver-related conditions.

Latest Patents

Yun-Ping Lee's latest patents include a kit for in vitro quantifying large surface protein of hepatitis B virus (HBV) and a biomarker set for analyzing phases of HBV infection and hepatoma prognosis. The kit comprises monoclonal antibodies that specifically bind to regions of the large surface protein, enhancing the sensitivity and dynamic range of detection in biological samples. Additionally, the biomarker set can be recognized by these antibodies, allowing for non-invasive analysis of HBV infection phases and hepatoma prognosis. Another significant aspect of his work involves a set of monoclonal antibodies aimed at predicting, diagnosing, or treating chronic liver disease, which can be crucial for patients in need.

Career Highlights

Throughout his career, Yun-Ping Lee has worked with esteemed institutions such as the National Health Research Institutes and National Cheng-Kung University. His research has focused on developing innovative solutions for complex medical challenges, particularly in the realm of liver diseases.

Collaborations

Yun-Ping Lee has collaborated with notable colleagues, including Wenya Huang and Ih-Jen Su. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Yun-Ping Lee's contributions to medical research through his patents demonstrate his commitment to improving healthcare outcomes for patients with hepatitis B and chronic liver diseases. His innovative approaches and collaborations highlight the importance of research in addressing critical health issues.